Requadt Scott 4
4 · Talaris Therapeutics, Inc. · Filed Jul 28, 2022
Insider Transaction Report
Form 4
Requadt Scott
DirectorSee Remarks
Transactions
- Purchase
Common Stock
2022-07-28$4.25/sh+3,090$13,133→ 469,298 total - Purchase
Common Stock
2022-07-26$4.24/sh+5,528$23,439→ 466,208 total
Holdings
- 449,766(indirect: See Footnote)
Common Stock
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.18 to $4.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]These shares are held by Requadt Family Limited Partnership. The Reporting Person has voting and dispositive power over the shares beneficially owned by Requadt Family Limited Partnership.